Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Clinical trial NCT01309945 · COMPLETED
Trial details
- NCT number
- NCT01309945
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2013-01-01
- Enrollment
- 889
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.